Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Information Requested for MedWatch Reports of Valvular Dysfunction

1. Patient age, sex, weight, height, blood pressure.

2. Daily dosage of fenfluramine, dexfenfluramine, phentermine.

3. Duration of use of appetite suppressant drugs.

4. If patient was no longer taking appetite suppressant drugs at the time of echocardiography, the interval of time since stopping use of these products.

5. Clinical history including symptoms (if any) and presence/absence of an audible cardiac murmur.

6. Echocardiogram results:

  1. Presence of regurgitation at each valve, especially at the aortic and mitral valves.
  2. Severity grading of regurgitation.
  3. Presence of pulmonary hypertension and estimated pulmonary artery pressure.

7. Use of other medications.

Related Information

Contact FDA

1-800-FDA-0178 Fax
Report a Serious Problem

MedWatch Online

Regular Mail: Use postage-paid FDA Form 3500

Mail to: MedWatch 5600 Fishers Lane

Rockville, MD 20857

Page Last Updated: 12/03/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English